相关文件明确，2026年1月1日起，所有医药机构都要实现药品追溯码全量采集上传。 一盒药品的追溯码，一般只有一次被扫码销售的记录，若重复出现多次，则存在假药、回流药或药品被 串换销售的可能。消费者可以通过国家医保局微信公众号"药品追溯信息查询"功能，扫描药盒上的药品 追溯码，获取详细的药品销售信息。 转自：天津日报 据新华社北京12月25日电 作为每盒药品的"电子身份证"，药品追溯码具有唯一性，是打击回流药的重 要抓手。国家医保局最新消息显示，截至目前，生产流通端已累计采集药品追溯码约440.8亿条，定点 医药机构端采集药品追溯码达1014.81亿条。 （来源：天津日报） ...

相关文件明确，2026年1月1日起，所有医药机构都要实现药品追溯码全量采集上传。 目前，我国常见的药品追溯码有三种：一是"码上放心"追溯码，也就是最常见的20位条形码；二是部分 药品生产企业自行设定的编码标准，用于各自企业生产药品的追溯码，也以数字为主；三是国际GS1 （全球统一编码标识系统）编码，载体为二维码，多见于进口药品。全球已经有150多个国家和地区的 116个编码组织加入了GS1。 （来源：衢州日报） 转自：衢州日报 新华社北京12月25日电 （记者 彭韵佳） 作为每盒药品的"电子身份证"，药品追溯码具有唯一性，是打 击回流药的重要抓手。国家医保局最新消息显示，截至目前，生产流通端已累计采集药品追溯码约 440.8亿条，定点医药机构端采集药品追溯码达1014.81亿条。 一盒药品的追溯码，一般只有一次被扫码销售的记录，若重复出现多次，则存在假药、回流药或药品被 串换销售的可能。消费者可以通过国家医保局微信公众号"药品追溯信息查询"功能，扫描药盒上的药品 追溯码，获取详细的药品销售信息。 ...

格隆汇12月25日｜据央视，作为每盒药品的"电子身份证"，药品追溯码具有唯一性，是打击回流药的重 要抓手。国家医保局最新消息显示，截至目前，生产流通端已累计采集药品追溯码约440.8亿条，定点 医药机构端采集药品追溯码达1014.81亿条。相关文件明确，2026年1月1日起，所有医药机构都要实现 药品追溯码全量采集上传。消费者可以通过国家医保局微信公众号"药品追溯信息查询"功能，扫描药盒 上的药品追溯码，获取详细的药品销售信息。 ...

目前，我国常见的药品追溯码有三种：一是"码上放心"追溯码，也就是最常见的20位条形码；二是部分 药品生产企业自行设定的编码标准，用于各自企业生产药品的追溯码，也以数字为主；三是国际GS1 （全球统一编码标识系统）编码，载体为二维码，多见于进口药品。全球已经有150多个国家和地区的 116个编码组织加入了GS1。 一盒药品的追溯码，一般只有一次被扫码销售的记录，若重复出现多次，则存在假药、回流药或药品被 串换销售的可能。消费者可以通过国家医保局微信公众号"药品追溯信息查询"功能，扫描药盒上的药品 追溯码，获取详细的药品销售信息。 （文章来源：新华网） 作为每盒药品的"电子身份证"，药品追溯码具有唯一性，是打击回流药的重要抓手。国家医保局最新消 息显示，截至目前，生产流通端已累计采集药品追溯码约440.8亿条，定点医药机构端采集药品追溯码 达1014.81亿条。 相关文件明确，2026年1月1日起，所有医药机构都要实现药品追溯码全量采集上传。 ...

这里是《21健讯Daily》，欢迎与21世纪经济报道新健康团队共同关注医药健康行业最新事件！ 政策动向 《中药饮片追溯码编码规则》公开征求意见 12月23日，据国家医保局官微，为积极推动药品全品种生产流通使用过程追溯和药品追溯码在医疗保障 领域的全流程、全量采集和全场景应用，加快推进中药饮片纳入全国统一药品追溯体系、实现"一物一 码、全程可溯"，国家医保局遵循"唯一性、通用性、实用性、可扩展性"原则，研究形成《中药饮片追 溯码编码规则》。现面向社会公开征求意见，欢迎公众围绕《中药饮片追溯码编码规则（征求意见 稿）》的编码结构、关键信息、追溯衔接、技术适配、实施落地等方面提出宝贵意见建议，以书面或电 子邮件形式反馈我局，意见反馈截止时间为2026年1月6日18:00。 《互联网药品医疗器械信息服务备案管理规定》发布 12月22日，国家药监局发布《互联网药品医疗器械信息服务备案管理规定》，自发布之日起施行。《规 定》明确了互联网药品医疗器械信息服务备案的内容、办理条件、工作程序、所需资料等相关事项。 12月23日，太极集团(600129.SH)公告称，公司全资子公司太极集团重庆涪陵制药厂有限公司持有参股 公司重庆 ...

Group 1 - Starting from July 1, medical insurance designated pharmaceutical institutions must scan the drug traceability code before settling with the medical insurance fund; failure to do so will result in rejection of payment [1] - By January 1, 2026, all medical institutions are required to fully collect and upload drug traceability codes [1] - The drug traceability code serves as the "electronic ID" of the drug, ensuring that each box of medication has a unique scanning record, preventing the sale of counterfeit or swapped drugs [1] Group 2 - Consumers can check the sales information of a drug by scanning the traceability code using the National Medical Insurance Bureau's WeChat public account [1] - If a consumer queries and finds "only 1 sales record," it indicates the drug is legitimate; if it shows multiple sales records, it may suggest the drug is counterfeit or has been resold [2][3] - Information obtained from software or apps outside the medical insurance department may not reflect the actual sales settlement information of the drug [3]

Core Viewpoint - Starting from today, all designated medical institutions in China must scan the "drug traceability code" for drug sales, which is essential for medical insurance fund settlement. By January 1, 2026, all medical institutions are required to fully collect and upload drug traceability codes [1][10]. Drug Traceability Code Scanning Process - The process for scanning the drug traceability code involves accessing the National Medical Insurance Bureau's WeChat public account, selecting the service option, and entering the drug traceability information query page [1][2]. - The scanning results can yield four possible outcomes, ranging from no sales information found to multiple sales records indicating potential issues with the drug's legitimacy [3][4][5]. Types of Traceability Codes - Traceability codes are categorized into three levels: large code, medium code, and small code, each serving different packaging units and purposes [6][7][9]. - The smallest traceability code is assigned to individual boxes, while medium and large codes are used for larger packaging, facilitating easier verification for companies [9]. Implementation and Regulation - Since the nationwide implementation of drug traceability code collection began in 2024, a total of 39.885 billion traceability codes have been aggregated [10]. - The National Medical Insurance Bureau has identified and is addressing fraudulent activities related to the sale of "returned drugs" and other illegal practices [15][17]. Consumer Rights and Responsibilities - Consumers are advised to follow six principles when purchasing drugs to protect their rights, including ensuring the presence of a traceability code, verifying the code during payment, and retaining receipts [18].

Core Viewpoint - The implementation of drug traceability codes starting from July 1 aims to enhance the management of medical insurance drugs and combat fraud in the healthcare system [1][3][4]. Group 1: Drug Traceability Code Implementation - From July 1, all designated medical institutions must record the full traceability information of drugs sold under medical insurance, adhering to the standards of "full collection, code-based settlement, and code-based payment" [3][4]. - The traceability code serves as a unique "electronic ID" for each drug, ensuring that each box of medicine has a distinct code that cannot be replicated [4][5]. - By January 1, 2026, all medical institutions must fully upload traceability codes, establishing a complete drug traceability loop [4][5]. Group 2: Consumer Protection and Rights - Consumers can verify the sales history of a drug using the traceability code, which can serve as crucial evidence for protecting their rights [7][8]. - The National Medical Insurance Administration provides guidelines for consumers to ensure they only purchase drugs with valid traceability codes and to report any suspicious sales [8][9]. - Legal provisions allow consumers to claim significant compensation for purchasing counterfeit or substandard drugs, reinforcing consumer rights [8][9]. Group 3: Impact on the Pharmaceutical Industry - The traceability system is expected to reduce management costs by approximately 20% and improve operational efficiency by over 30% for pharmaceutical companies [10]. - The comprehensive application of drug traceability codes is anticipated to create a healthier and more compliant ecosystem in the pharmacy industry, facilitating a smoother implementation of policies [10][11]. - The transition to a digitalized pharmaceutical industry is seen as a new starting point for the sector, potentially leading to a surge in innovative drug listings [11].

Group 1 - The implementation of drug traceability codes will reshape the management ecosystem of medical insurance drugs in China, with a focus on preventing fraud and ensuring compliance [2][4][9] - Starting from July 1, 2025, new drug purchases must be scanned for traceability codes to settle medical insurance claims, while existing unmarked drugs will be managed under a transitional "unmarked library" [3][4] - By January 1, 2026, all medical institutions must fully collect traceability codes, establishing a complete drug traceability loop [3] Group 2 - The unique design of traceability codes, which includes features like uniqueness and detailed management, is crucial for regulatory effectiveness [2] - As of March 20, 2025, over 350 pharmaceutical production and distribution companies have connected to the traceability platform, with nearly 8,000 companies inquiring about the upload and query process [2] - The traceability code system is expected to reduce management costs by 20% and improve operational efficiency by over 30% for companies integrating with the national traceability platform [7] Group 3 - Consumers can verify drug sales and protect their rights using traceability codes, which should only have one sales record [6] - The current legal framework provides strong protections for consumers against fraud, allowing for significant compensation in cases of selling counterfeit drugs [7] - The comprehensive application of traceability codes is seen as a new starting point for the digital transformation of the pharmaceutical industry [9]

Core Points - Starting from July 1, medical institutions designated for medical insurance must scan the drug traceability code before settling with the medical insurance fund; by January 1, 2026, all medical institutions must fully collect and upload drug traceability codes [1] - The drug traceability code serves as the "electronic ID" for drugs, ensuring that each box of medication has a unique scanning record, preventing the sale of counterfeit, returned, or swapped drugs [1] - Consumers can use the National Medical Insurance Administration's WeChat public account to scan the traceability code on drug packaging to obtain detailed sales information [1] Drug Traceability Code Usage - To check drug sales information, consumers can follow these steps: access the National Medical Insurance Administration's WeChat public account, navigate to the drug traceability information query, and scan the QR code or barcode on the drug packaging [1] - If the query shows "only 1 sales record," it indicates the drug is legal and compliant if it matches the consumer's purchase; otherwise, it may indicate the drug has been resold, potentially being a returned, swapped, or counterfeit drug [2] - If the query shows "2 or more sales records," it suggests the drug has been sold previously; information obtained from non-official software or apps may not reflect the drug's medical insurance sales settlement information [3]